Nevena Damnjanov, MD of Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses how she reliably identifies subgroups for targeted therapies in HCC at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Identifying subgroups for targeted therapies in HCC
